CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Booth Andrew Chief Financial Officer | Purchase | +37,200 | $10.32 | $384K | 482,800 |
| 2026-06-03 | Booth Andrew Chief Financial Officer | Option exercise | +250,000 | $0.19 | $48K | 445,600 |
| 2026-06-03 | Booth Andrew Chief Financial Officer | Option exercise · Share option (right to buy) | −250,000 | 8,501,849 | ||
| 2026-02-27 | Booth Andrew Chief Financial Officer | Purchase | +42,600 | $3.42 | $146K | 195,600 |
| 2026-01-01 | Booth Andrew Chief Financial Officer | Grant or award · Share option (right to buy) | +808,898 | 8,751,849 | ||
| 2025-01-01 | Booth Andrew Chief Financial Officer | Grant or award · Share option (right to buy) | +1,352,054 | 7,942,951 | ||
| 2024-01-14 | Booth Andrew Chief Financial Officer | Grant or award · Share option (right to buy) | +770,416 | 6,590,897 | ||
| 2023-05-26 | Booth Andrew Chief Financial Officer | Purchase | +14,500 | $6.85 | $99K | 153,000 |
| 2022-12-20 | Booth Andrew Chief Financial Officer | Option exercise | +50,000 | $0.19 | $10K | 188,500 |
| 2022-12-20 | Booth Andrew Chief Financial Officer | Gift | −50,000 | 138,500 | ||
| 2022-12-20 | Booth Andrew Chief Financial Officer | Option exercise · Share option (right to buy) | −50,000 | 5,820,481 | ||
| 2022-12-01 | Booth Andrew Chief Financial Officer | Grant or award · Share Options (right to buy) | +485,661 | 5,870,481 | ||
| 2022-05-12 | Booth Andrew Chief Financial Officer | Purchase | +85,000 | $5.79 | $492K | 138,500 |
| 2021-12-10 | Booth Andrew Chief Financial Officer | Option exercise | +500,000 | $0.32 | $160K | 553,500 |
| 2021-12-10 | Booth Andrew Chief Financial Officer | Option exercise · Share Options (right to buy) | −500,000 | 5,384,820 | ||
| 2021-12-07 | Booth Andrew Chief Financial Officer | Grant or award · Share Option (right to buy) | +406,020 | 5,884,820 | ||
| 2021-11-11 | Booth Andrew Chief Financial Officer | Purchase | +53,500 | $14.74 | $789K | 53,500 |
| 2021-11-11 | Booth Andrew Chief Financial Officer | Purchase | +14,000 | $14.61 | $205K | 130,959 |
| 2021-06-09 | Booth Andrew Chief Financial Officer | Sale | −1,200,000 | $25.50 | $30.6M | 0 |
| 2021-06-07 | Booth Andrew Chief Financial Officer | Option exercise | +600,000 | $0.19 | $114K | 600,000 |
Page 1 of 2 · 23 trades